FDA Inspection 660339 — Biomat USA Inc

Biomat USA Inc — FEI 2077733

The FDA completed an inspection of Biomat USA Inc on Apr 21, 2010 in Reseda, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 21, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Reseda, CA (United States)

Citations

IDCFRDescription
15521 CFR 606.160(b)Required records
6721 CFR 606.65(e)Following manufacturer's instructions
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
924121 CFR 630.40(a)Supplemental results
924321 CFR 630.40(a)Notification